Yale NewsNew cancer immunotherapy drugs rapidly reach patients after approvalYale NewsThe majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a… Continue reading
New cancer immunotherapy drugs rapidly reach patients after approvalEurekAlert (press release)The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, accord… Continue reading
New cancer immunotherapy drugs rapidly reach patients after approvalEurekAlert (press release)The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, accord… Continue reading
R & D Magazine |
Scientists Use CRISPR to Improve Cacao Trees, Key to Chocolate
R & D Magazine Use of the powerful gene-editing tool CRISPR-Cas9 could help to breed cacao trees that exhibit desirable traits such as enhanced resistance to diseases, according to Penn State plant scientists. The cacao tree, which grows in tropical regions, produces … Video: Can CRISPR gene editing help solve world’s food and farming challenges?Genetic Literacy Project Global Market and Potential for CRISPR/Cas9 Gene Editing to 2023GlobeNewswire (press release) CRISPR stocks deserve a second look: Here’s whyAnalyst Ratings Post Analyst –Motley Fool –Motley Fool –Seeking Alpha all 38 news articles » |
EurekAlert (press release) |
Cocoa CRISPR: Gene editing shows promise for improving the ‘chocolate tree’
EurekAlert (press release) Use of the powerful gene-editing tool CRISPR-Cas9 could help to breed cacao trees that exhibit desirable traits such as enhanced resistance to diseases, according to Penn State plant scientists. The cacao tree, which grows in tropical regions, produces … |
STAT |
Eli Lilly acquires small biotech for $1.6 billion to strengthen cancer immunotherapy pipeline
STAT li Lilly is buying into the cancer immunotherapy business. In a deal announced Thursday, Lilly said it will acquire a small biotech, ARMO Biosciences, for $50 per share, or $1.6 billion. The transaction values ARMO shares at a 68 percent premium to … Lilly Is Spending $1.6 Billion To ‘Leapfrog’ Merck, Bristol — Will It Work?Investor’s Business Daily Eli Lilly Makes A Bold Acquisition; How Lucrative Is It? – Eli Lilly and …Seeking Alpha How this biotech nearly tripled its IPO price with a buyout in less than 4 monthsSan Francisco Business Times FierceBiotech –Zacks –StreetInsider.com –24/7 Wall St. all 201 news articles » |